Physician profile
Adrienne S Glaich
NPI 1699938563
$17,123.34
in general payments reported to CMS, 2019-2025
33 companies · $3,148 in 2025
The $3,148 reported for 2025 was more than what a typical Clinical & Laboratory Dermatological Immunology provider received nationally (typical 2025 total: $1,130).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,721 · 2020: $1,171 · 2021: $2,325 · 2022: $2,567 · 2023: $2,983 · 2024: $3,209 · 2025: $3,148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,200 · Education: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,199.61 |
| Education | $139.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,502.92 | 2019-2025 | |
| Janssen Biotech, INC. | $1,605.85 | 2019-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $1,287.06 | 2019-2025 | Dupixent, Libtayo |
| Incyte Corporation | $1,142.59 | 2021-2025 | Opzelura |
| Pfizer INC. | $976.86 | 2019-2025 | |
| Genzyme Corporation | $709.03 | 2023-2025 | |
| Arcutis Biotherapeutics, INC. | $674.79 | 2023-2025 | Zoryve |
| Lilly USA, LLC | $670.25 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Leo Pharma INC. | $665.14 | 2019-2025 | Adbry, Anzupgo |
| Amgen INC. | $604.47 | 2020-2025 | Otezla, Otezla |
| Sun Pharmaceutical Industries INC. | $563.33 | 2019-2025 | Ilumya |
| Galderma Laboratories, L.P. | $395.48 | 2019-2025 | Nemluvio, Aklief |
| E.R. Squibb & Sons, L.L.C. | $388.45 | 2022-2025 | Sotyktu |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $378.06 | 2019-2025 | Cabtreo, Jublia, Arazlo |
| Revance Therapeutics, INC. | $290.11 | 2024 | Daxxify |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $284.04 | 2023-2024 | Vtama |
| Organon LLC | $278.36 | 2025 | Vtama |
| Allergan, INC. | $263.98 | 2021 | |
| Vyne Pharmaceuticals INC. | $231.46 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $205.23 | 2019-2025 | |
| Ucb, INC. | $194.12 | 2019-2025 | Bimzelx |
| Biofrontera INC. | $136.98 | 2019-2025 | Xepi, Bf-Rhodoled, Ameluz |
| Epi Health, LLC | $136.15 | 2019-2021 | |
| Celgene Corporation | $126.80 | 2019 | |
| Janssen Scientific Affairs, LLC | $96.54 | 2020-2022 | |
| Almirall LLC | $81.50 | 2021-2023 | Klisyri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.93 | 2022-2023 | Spevigo |
| Journey Medical Corporation | $43.39 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $33.06 | 2023-2025 | |
| Sandoz INC. | $31.88 | 2023 | Hyrimoz |
| Springworks Therapeutics, INC. | $25.42 | 2025 | Gomekli |
| Botanix Sb INC | $22.42 | 2025 | Sofdra |
| Mylan Pharmaceuticals INC. | $17.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adrienne Glaich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.